Events

In addition to the DPAC Stage presentations, Venture Connect features a dynamic lightning round where emerging technology companies present rapid-fire pitches.

This session showcases software companies using artificial intelligence, automation, and modern cloud platforms to solve real-world problems across healthcare, construction, education, finance, and beyond. What unites them is a commitment to replacing inefficiency with intelligence — and delivering measurable impact to the people and organizations they serve. Thank you to our sponsors, Michael Best & […]

In addition to the DPAC Stage presentations, Venture Connect features a dynamic lightning round where emerging life science companies present rapid-fire pitches.

We are excited to host an invite-only Biotech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow biotech investors over lunch and engage in insightful […]

Take a break, grab a bite, and connect organically with fellow attendees. This unscripted, unstructured lunch is your time to step outside, spark new conversations, and build relationships in a […]

The companies in this session are confronting some of the most pressing environmental and agricultural challenges of our time. From climate-resilient crops to next-generation water treatment and sustainable seafood, these […]

Transaction readiness isn’t a last-minute sprint—it’s the result of disciplined decisions made years earlier. In this session, Tyson Nargassans, CED Founder in Residence and CEO of Slope Software, shares hard-won […]

At their best, Boards can be a founder's most valuable asset, providing the right level of accountability, invaluable strategic advice, and connections that lead directly to new knowledge, revenue, or […]

The companies in this session are operating at the frontier of what hardware and deep technology can do. From advanced robotics and satellite systems to novel materials and semiconductor architecture, […]

In addition to the DPAC Stage presentations, Venture Connect features a dynamic lightning round where emerging technology companies present rapid-fire pitches.

Join a respected panel of growth-stage investors (moderated by Peter Franconi of Fulcrum Equity Partners) as they discuss relevant topics ranging from the capital raising environment to the prevalence of […]

Given the long roadmaps, most life science companies are going to exit well before revenue and some exit much earlier than originally planned. How did these opportunities unfold? How did […]